TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

R Fagerholm, S Khan, MK (Marjanka) Schmidt, M Garcia-Closas, P Heikkila, J Saarela, J Beesley, M Jamshidi, K Aittomaki, JJ Liu, HR Ali, IL Andrulis, MW Beckmann, S Behrens, FM Blows, H Brenner, J Chang-Claude, FJ Couch, K Czene, PA FaschingJ Figueroa, G Floris, G Glendon, Q Guo, P Hall, E Hallberg, U Hamann, B Holleczek, Maartje Hooning, JL Hopper, Agnes Jager, M Kabisch, R Keeman, VM Kosma, D Lambrechts, A Lindblom, A Mannermaa, S Margolin, E Provenzano, M Shah, MC Southey, J Dennis, M Lush, K Michailidou, Q Wang, MK Bolla, AM Dunning, DF Easton, PDP Pharoah, G Chenevix-Trench, C Blomqvist, H Nevanlinna

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)
3 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)18381-18398
Number of pages18
JournalOncotarget
Volume8
Issue number11
DOIs
Publication statusPublished - 2017

Cite this